Philippines
+918265041513
+918265041513
Gynaecology

Pergoveris 450IU Pen Injection Canada,South Africa, Australia,United Kingdom,United States.

In stockcod not available
Phone Number

+918265041513

Email Address unnatipharmax@gmail.com

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address Metro Manila , Philippines

Philippines, Philippines, 1000

Description

Pergoveris 450IU Pen Injection contains follitropin alfa 450 IU (recombinant FSH) and lutropin alfa 225 IU (recombinant LH) in 0.72 mL solution. It is a prescription gonadotropin medicine used to stimulate follicular development in adult women with severe FSH and LH deficiency as part of fertility treatment. ๎ˆ The medicine is supplied as a multi-dose pre-filled pen and is administered by subcutaneous injection. Treatment should be initiated and monitored by a fertility specialist, with dosage individualized according to the patient's ovarian response. Gonadotropin treatment requires monitoring because excessive ovarian stimulation can lead to ovarian hyperstimulation syndrome (OHSS). Active Ingredients: Follitropin Alfa 450 IU + Lutropin Alfa 225 IU Dosage Form: Solution for Injection Volume: 0.72 mL Route: Subcutaneous Drug Class: Gonadotropin / Recombinant FSH + LH Category: Fertility & Infertility Treatment Primary Use: Follicular stimulation in women with severe FSH/LH deficiency.

Keywords

Other Products

view all

68179d65be22ee500d53ff54 Card 2

product image
Neurology

USA,United Kingdom,Canada,Australia,Singapore,Philippines Dexlog Injection is an injectable corticosteroid preparation containing dexamethasone, a potent glucocorticoid. It is used under medical supervision to reduce inflammation and allergic or immune-mediated reactions. Common therapeutic uses may include: Severe allergic or inflammatory conditions Asthma and respiratory inflammatory conditions Certain rheumatic or autoimmune disorders Skin and other inflammatory conditions As part of specific hospital treatment protocols Key point: Dexamethasone injections should be administered only by a qualified healthcare professional and used according to the prescribed indication and dose.

68179d65be22ee500d53ff54 Card 2

product image
Anticoagulant

USA, Canada,South America,United Kingdom,South Africa, Atrawem Injection 2.5 mL contains Atracurium Besylate 10 mg/mL and belongs to the class of non-depolarizing neuromuscular blocking agents (muscle relaxants). It is used in hospitals during general anesthesia to provide skeletal muscle relaxation, facilitate endotracheal intubation, and assist controlled/mechanical ventilation during surgery or intensive-care treatment. Key details: Brand: Atrawem Injection Composition: Atracurium Besylate 10 mg/mL Pack: 2.5 mL ampoule/vial Therapeutic class: Neuromuscular blocking agent Main use: Muscle relaxation during surgery and airway management Administration: IV by a qualified healthcare professional Storage: Refrigerated at 2โ€“8ยฐC; do not freeze. Important: Atrawem is a hospital-use injectable and must not be self-administered; it can cause profound muscle paralysis and requires appropriate airway and respiratory support.

68179d65be22ee500d53ff54 Card 2

product image
Neurology

Exelon 4.5mg Capsule Australia,Philippines,USA,South Korea, India, South Africa,Singapore. Exelon 4.5mg Capsule contains rivastigmine 4.5mg, a cholinesterase inhibitor used for the symptomatic treatment of mild to moderate Alzheimerโ€™s disease and dementia associated with Parkinsonโ€™s disease. Key Information: Active Ingredient: Rivastigmine 4.5mg Dosage Form: Capsule Therapeutic Category: Neurology / CNS Medicines Drug Class: Cholinesterase Inhibitor Uses: Alzheimerโ€™s disease and Parkinsonโ€™s disease dementia How it works: Helps increase acetylcholine activity in the brain, which may support memory, thinking, and daily functioning. Administration: Take exactly as prescribed by a healthcare professional. Common Side Effects: Nausea, vomiting, diarrhea, decreased appetite, dizziness, and abdominal discomfort. Important: Exelon 4.5mg is a prescription medicine. The dose and treatment schedule should be determined by a healthcare professional.